Results 261 to 270 of about 78,176 (327)

Intravesical oxybutynin for bladder capacity in children with spina bifida: the ‘Place de l’OXybutynine Intravésicale chez le Patient Enfant Neurologique’ (POXIPEN) trial protocol

BJU International, Volume 137, Issue 2, Page 390-398, February 2026.
Background Neurogenic bladder is defined as a dysfunction of the bladder resulting from damage to the central or peripheral nervous systems. Its treatment is based on a progressive therapeutic escalation, rapidly involving invasive therapeutic procedures such as repeated intradetrusor injections and surgery.
Marie Buzzi, Jonathan Epstein, Zahi Hatem, Nadine Juge, Charles Mazeaud, Jean‐Louis Lemelle, Nicolas Berte   +6 more
wiley   +1 more source

Is Bipolar Radiofrequency Thermotherapy a Reliable Treatment for Benign Prostatic Hyperplasia in Elderly Patients Ineligible for General and Spinal Anesthesia? [PDF]

Cureus
Efendioglu F, Özcan C, Asgarli S, Cinar O, Sarikaya S, Ünal B, Bedir S.   +6 more
europepmc   +1 more source

Drug‐releasing intravesical floating technology for sequential gemcitabine and docetaxel in non‐muscle‐invasive bladder cancer

BJU International, Volume 137, Issue 2, Page 360-367, February 2026.
Objectives To develop a drug‐releasing intravesical floating technology (DRIFT) device for controlled sequential delivery of gemcitabine and docetaxel (Gem/Doce) to optimise the treatment of non‐muscle‐invasive bladder cancer (NMIBC) while enabling patient mobility and self‐removal, as sequential intravesical Gem/Doce has been increasingly utilised but
Ashley C. Rhodes, Kaitlyn A. McClintic, Emily Witt, Ikenna Nwosu, Kyle R. Balk, Colin Reis, Ian C. Sutton, Jianling Bi, Melinda Z. Fu, Michael A. O’Donnell, Vignesh T. Packiam, James D. Byrne   +11 more
wiley   +1 more source

Vomiting, hypotonia and failure to thrive in a 12-month-old female. [PDF]

Paediatr Child Health
MacDonald BE, Acott PD, Burns E.
europepmc   +1 more source

Urologic chronic pelvic pain syndrome 3‐year symptom trajectories: the Multidisciplinary Approach to the Study of Chronic Pelvic Pain (MAPP) Symptom Patterns Study

BJU International, Volume 137, Issue 2, Page 312-322, February 2026.
Objectives To characterise 3‐year pelvic pain and urinary symptom trajectories and to identify baseline factors associated with urologic chronic pelvic pain syndrome (UCPPS) improvement. Patients and Methods The Trans‐Multidisciplinary Approach to the Study of Chronic Pelvic Pain (MAPP) Symptom Patterns Study was a multicentre, prospective cohort study
Catherine S. Bradley, Mengying You, Wensheng Guo, Niloofar Afari, Priyanka Gupta, Karl J. Kreder, John N. Krieger, H. Henry Lai, Susan K. Lutgendorf, Bruce D. Naliboff, Siobhan Sutcliffe, Frank Tu, David A. Williams, Tara McWilliams, Larissa Rodriguez, J. Richard Landis, for the Multidisciplinary Approach to the Study of Chronic Pelvic Pain (MAPP) Research Network   +16 more
wiley   +1 more source

Prevalence of selected curable sexually transmitted infections and predetermining factors among pregnant women attending antenatal care at Gebretsadik Shawo General Hospital, Bonga, Southwest Ethiopia: a cross-sectional study. [PDF]

BMJ Open
Kochito S, Fenta DA, Worku T, Mesfin G, Zenebe MH.   +4 more
europepmc   +1 more source

Body surface temperatures as biomarkers of physiological environmental adaptation in wild birds and mammals

Biological Reviews, Volume 101, Issue 1, Page 336-363, February 2026.
ABSTRACT The ability of individuals to cope with their environment, and therefore the likelihood that they survive and pass on their genes (i.e. fitness), is largely determined by physiological state. Tracking physiological state in wild animals, however, is challenging.
Paul Jerem, L. Michael Romero
wiley   +1 more source

A rare case of successful treatmeat of xanthogranulomatous prostatitis and literature reviews. [PDF]

Urol Case Rep
Zheng Y, Wang X, Tang S.
europepmc   +1 more source

Assessing the Benefits of “Circle”: A Patient Support Program for Neuromyelitis Optica Spectrum Disorder for Patients Receiving Satralizumab Treatment

Clinical and Experimental Neuroimmunology, Volume 17, Issue 1, February 2026.
ABSTRACT Objectives Although satralizumab, an interleukin‐6 receptor inhibitor, effectively prevents relapses in neuromyelitis optica spectrum disorder (NMOSD), infections are reported to be the most common adverse reactions. To support Japanese patients receiving satralizumab, “Circle”—a 1‐year patient support program—was developed.
Kazuo Fujihara, Chiaki Sugita, Katsuhisa Yamashita, Yuta Kamei   +3 more
wiley   +1 more source

Disseminated gonorrhea presenting as cellulitis of the hand: A case report. [PDF]

SAGE Open Med Case Rep
Gurram A, Karnath N, Nanduri RS, Roy K, Karnath B.   +4 more
europepmc   +1 more source